Regeneron Pharmaceuticals SG&A Expense (Quarterly) Trends

Regeneron Pharmaceuticals Inc (REGN)

906.80 -0.10 (-0.01%) USD | NASDAQ | Apr 24, 16:00

906.80 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1991. Upgrade now.

Date	Value
December 31, 2023	737.70M
September 30, 2023	640.50M
June 30, 2023	652.00M
March 31, 2023	601.10M
December 31, 2022	660.50M
September 30, 2022	529.10M
June 30, 2022	476.30M
March 31, 2022	450.00M
December 31, 2021	559.60M
September 30, 2021	445.00M
June 30, 2021	414.70M
March 31, 2021	405.60M
December 31, 2020	303.50M
September 30, 2020	326.90M
June 30, 2020	348.30M
March 31, 2020	367.30M
December 31, 2019	451.80M
September 30, 2019	304.40M
June 30, 2019	294.60M
March 31, 2019	291.10M
December 31, 2018	62.30M
September 30, 2018	369.20M
June 30, 2018	364.80M
March 31, 2018	330.80M
December 31, 2017	409.88M

Date	Value
September 30, 2017	306.77M
June 30, 2017	306.91M
March 31, 2017	296.85M
December 31, 2016	325.94M
September 30, 2016	270.04M
June 30, 2016	292.04M
March 31, 2016	289.68M
December 31, 2015	294.95M
September 30, 2015	209.99M
June 30, 2015	174.59M
March 31, 2015	158.99M
December 31, 2014	175.31M
September 30, 2014	144.00M
June 30, 2014	96.73M
March 31, 2014	103.23M
December 31, 2013	99.06M
September 30, 2013	97.61M
June 30, 2013	72.46M
March 31, 2013	77.26M
December 31, 2012	57.74M
September 30, 2012	46.88M
June 30, 2012	47.70M
March 31, 2012	58.43M
December 31, 2011	36.35M
September 30, 2011	32.92M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

294.60M

Minimum

Jun 2019

737.70M

Maximum

Dec 2023

472.05M

Average

450.00M

Median

Mar 2022

SG&A Expense (Quarterly) Benchmarks